Your browser doesn't support javascript.
loading
The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia.
Eyre, Toby A; Roeker, Lindsey E; Fox, Christopher P; Gohill, Satyen H; Walewska, Renata; Walter, Harriet S; Forconi, Francesco; Broom, Angus; Arumainathan, Arvind; Brander, Danielle M; Allan, John N; Schuster, Stephen J; Hill, Brian T; Lansigan, Frederick; Cheson, Bruce D; Lamanna, Nicole; Coombs, Catherine C; Barr, Paul M; Skarbnik, Alan P; Shadman, Mazyar; Ujjani, Chaitra S; Pearson, Laurie; Pagel, John M; Jacobs, Ryan; Mato, Anthony R.
Afiliação
  • Eyre TA; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Roeker LE; Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Fox CP; Department of Clinical Haematology, Nottingham University Hospitals NHS Foundation Trust, Nottingham, UK.
  • Gohill SH; Department of Haematology, University College London Hospitals, London, UK.
  • Walewska R; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Walter HS; Department of Oncology, Leicester Royal Infirmary, Leicester, UK.
  • Forconi F; Department of Haematology, University Hospital Trust and Cancer Sciences Unit, Cancer Research, Southampton, UK.
  • Broom A; National Institute for Health Research Experimental Cancer Medicine Centres, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Arumainathan A; Department of Haematology, Western General Hospital, Edinburgh, UK.
  • Brander DM; Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK.
  • Allan JN; Duke Cancer Institute, Duke University Health System, Durham, NC, USA.
  • Schuster SJ; Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA.
  • Hill BT; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Lansigan F; Department of Hematology & Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Cheson BD; Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
  • Lamanna N; Georgetown University Hospital Lombardi Comprehensive Cancer Center, Washington, DC, USA.
  • Coombs CC; Hematology/Oncology Division, Columbia University Medical Center, New York, NY, USA.
  • Barr PM; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
  • Skarbnik AP; Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA.
  • Shadman M; Novant Health, Charlotte, NC, USA.
  • Ujjani CS; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Pearson L; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Pagel JM; Tufts Medical Center, Boston, MA, USA.
  • Jacobs R; Swedish Cancer Institute, Seattle, WA, USA.
  • Mato AR; Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC, USA.
Br J Haematol ; 188(6): 918-923, 2020 03.
Article em En | MEDLINE | ID: mdl-31682002
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Leucemia Linfocítica Crônica de Células B / Compostos Bicíclicos Heterocíclicos com Pontes / Antineoplásicos Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Leucemia Linfocítica Crônica de Células B / Compostos Bicíclicos Heterocíclicos com Pontes / Antineoplásicos Idioma: En Ano de publicação: 2020 Tipo de documento: Article